结直肠癌肝转移；当前情况
Colorectal liver metastases; the current scenario.
作者信息
Pathak Samir, Poston Graeme J
机构信息
Department of General Surgery, University Hospital Aintree, Liverpool, UK.
出版信息
Indian J Surg Oncol. 2010 Dec;1(4):350-5. doi: 10.1007/s13193-011-0066-6. Epub 2011 Apr 19.
Abstract
Colorectal cancer is the most common gastrointestinal malignancy. When metastases occurs, it most frequently occurs in the liver. Median survival without any treatment is poor, and until recently only a subset of patients were amenable to any form of surgical therapy. The following article aims to examine recent strategies used to increase the cohort of patients coming to curative oncological surgery.
摘要
结直肠癌是最常见的胃肠道恶性肿瘤。发生转移时，最常转移至肝脏。未经任何治疗的患者中位生存期较差，直到最近，只有一部分患者适合任何形式的手术治疗。以下文章旨在探讨最近用于增加接受根治性肿瘤手术患者队列的策略。
相似文献
1
Colorectal liver metastases; the current scenario.结直肠癌肝转移；当前情况
Indian J Surg Oncol. 2010 Dec;1(4):350-5. doi: 10.1007/s13193-011-0066-6. Epub 2011 Apr 19.
2
Liver resection surgery compared with thermal ablation in high surgical risk patients with colorectal liver metastases: the LAVA international RCT.肝切除术与热消融治疗结直肠癌肝转移高危患者的比较：LAVA 国际 RCT。
Health Technol Assess. 2020 Apr;24(21):1-38. doi: 10.3310/hta24210.
3
Multimodal treatment strategies for colorectal liver metastases.结直肠癌肝转移的多模态治疗策略。
Swiss Med Wkly. 2021 Feb 15;151:w20390. doi: 10.4414/smw.2021.20390.
4
Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival.结直肠肝转移瘤行肝切除术后手术切缘复发与 R1 切除无关，且不影响生存。
Surgery. 2021 May;169(5):1061-1068. doi: 10.1016/j.surg.2020.11.024. Epub 2020 Dec 30.
5
Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection.复发性结直肠癌肝转移的根治性治疗：消融与切除的比较
Eur J Surg Oncol. 2017 Oct;43(10):1901-1907. doi: 10.1016/j.ejso.2017.08.008. Epub 2017 Aug 26.
6
[Comparative study of ultrasound-guided percutaneous microwave ablation and surgical resection for colorectal cancer with liver metastasis].超声引导下经皮微波消融与手术切除治疗结直肠癌肝转移的对比研究
Zhonghua Yi Xue Za Zhi. 2020 Mar 10;100(9):696-701. doi: 10.3760/cma.j.issn.0376-2491.2020.09.010.
7
[Surgical therapy of colorectal liver metastases].[结直肠癌肝转移的外科治疗]
Praxis (Bern 1994). 2005 Dec 7;94(49):1943-8. doi: 10.1024/0369-8394.94.49.1943.
8
Liver resection surgery versus thermal ablation for colorectal LiVer MetAstases (LAVA): study protocol for a randomised controlled trial.肝切除手术与热消融治疗结直肠癌肝转移（LAVA）：一项随机对照试验的研究方案
Trials. 2018 Feb 13;19(1):105. doi: 10.1186/s13063-018-2499-5.
9
Prognostic factors and therapeutic effects of different treatment modalities for colorectal cancer liver metastases.结直肠癌肝转移不同治疗方式的预后因素及治疗效果
World J Gastrointest Oncol. 2020 Oct 15;12(10):1177-1194. doi: 10.4251/wjgo.v12.i10.1177.
10
Management of colorectal liver metastases.结直肠癌肝转移的管理
Colorectal Dis. 2003 Jan;5(1):2-23. doi: 10.1046/j.1463-1318.2003.00410.x.
引用本文的文献
1
Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications.结直肠癌的免疫基因组分类及治疗意义。
Int J Mol Sci. 2017 Oct 24;18(10):2229. doi: 10.3390/ijms18102229.
2
[Liver metastases of colorectal cancer].[结直肠癌肝转移]
Radiologe. 2017 Feb;57(2):90-96. doi: 10.1007/s00117-017-0208-0.
本文引用的文献
1
Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases.联合门静脉栓塞和新辅助化疗作为可切除肝结直肠癌转移灶的一种治疗策略。
Ann Surg. 2008 Mar;247(3):451-5. doi: 10.1097/SLA.0b013e31815ed693.
2
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.FOLFOX4围手术期化疗联合手术与单纯手术治疗可切除的结直肠癌肝转移（欧洲癌症研究与治疗组织（EORTC）国际协作组试验40983）：一项随机对照试验
Lancet. 2008 Mar 22;371(9617):1007-16. doi: 10.1016/S0140-6736(08)60455-9.
3
Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy.在接受术前化疗的结直肠癌肝转移患者中，肝血窦损伤会增加大肝切除术后的发病率。
Ann Surg. 2008 Jan;247(1):118-24. doi: 10.1097/SLA.0b013e31815774de.
4
Preoperative portal vein embolization for major liver resection: a meta-analysis.肝大部切除术前门静脉栓塞术：一项荟萃分析
Ann Surg. 2008 Jan;247(1):49-57. doi: 10.1097/SLA.0b013e31815f6e5b.
5
A primer on transarterial, chemical, and thermal ablative therapies for hepatic tumors.肝肿瘤经动脉、化学和热消融治疗入门
Am J Surg. 2007 Jul;194(1):79-88. doi: 10.1016/j.amjsurg.2006.11.025.
6
Meta-analysis of clinical outcome after first and second liver resection for colorectal metastases.结直肠癌肝转移首次和二次肝切除术后临床结局的Meta分析。
Surgery. 2007 Jan;141(1):9-18. doi: 10.1016/j.surg.2006.07.045. Epub 2006 Nov 17.
7
Surgical management of pulmonary metastases from colorectal cancer in 153 patients.153例结直肠癌肺转移患者的外科治疗
Ann Surg Oncol. 2006 Nov;13(11):1538-44. doi: 10.1245/s10434-006-9100-2. Epub 2006 Sep 29.
8
Towards a pan-European consensus on the treatment of patients with colorectal liver metastases.达成关于结直肠癌肝转移患者治疗的泛欧共识。
Eur J Cancer. 2006 Sep;42(14):2212-21. doi: 10.1016/j.ejca.2006.04.012. Epub 2006 Aug 10.
9
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.化疗方案可预测肝结直肠癌转移灶手术后的脂肪性肝炎及90天死亡率的增加。
J Clin Oncol. 2006 May 1;24(13):2065-72. doi: 10.1200/JCO.2005.05.3074.
10
Radiofrequency ablation of liver metastases from colorectal carcinoma.
Cancer Control. 2006 Jan;13(1):48-51. doi: 10.1177/107327480601300107.
Zotero 插件